Skip to main content


Aamir Hussain, MD, MAPP
Medical education faced changes from multiple angles in early 2020. Is it time for dermatology to approach testing to better evaluate students for residency applications?
Peter Sonnenreich, Mary Anne Dunkin
Concern over thinning hair drives both men and women to seek a variety of treatments. Dermatologists weigh in on some of the options for nonsurgical hair loss therapies.
Jason Emer, MD
While COVID-19 paused many of the day-to-day operations in aesthetic dermatology practices, physicians can begin to take steps to prepare their office for patients even during the pandemic.
Kristi Hawley, DO
Kristi Hawley, DO, reviews the link between diabetes, obesity, and psoriasis, as well as treatment considerations for this patient population.
Melissa Weiss, Associate Editor,, Richard Fried, MD, PhD
While the United States is entering a new period of the COVID-19 pandemic, with some states reopening or relaxing lockdowns, there are still a lot of uncertainties and anxieties. In an interview for The Dermatologist, Richard Fried, MD, board-certified dermatologist and clinical psychologist, spoke with me about how dermatologists can care for their mental health during the COVID-19 pandemic.
Melissa Weiss, Associate Editor
The following is an excerpt from our latest podcast with Dr Jonathan Silverberg on the rise and fall of hydroxychloroquine as a “wonder drug” for COVID-19 and the importance of evidence-based medicine.
Linda Susan Marcus, MD, FAAD
One major missing piece from dermatology now is the joy of the office and the warmth of human interaction. Recognizing the feelings of loss may help dermatologists move forward with their practice during the current atmosphere.
Ellen Anshelevich, BA, Bwanali Jereni, MBBS, Victoria Williams, MD
Oculocutaneous albinism can create challenges for health, psychosocial, and cultural reasons. Building a care program for people living with albinism and other neglected patient groups can dramatically improve quality of life.
William Damsky, MD, Brett King, MD
Janus kinase (JAK) inhibitors are an emerging drug class in dermatology. A further testament to their broad activity and potential importance across all of medicine, JAK inhibitors may be useful in some patients with COVID-19.
Steven Leon, MS, PA-C, Gene Rubinstein, MD, FAAD
Dermatology practices are under pressure to offer telemedicine for patient care and bottom lines. Improvements in teledermatology platforms make incorporation easier than ever before.
Back to Top